|
|
|
|
|
|
|
|
Condensed Separate Interim Cash Flows for the period ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
Notes
|
Sep. 30,
2024
|
|
Sep. 30,
2023
|
|
|
|
|
|
|
|
|
|
Cash flow from operating activities
|
|
|
|
|
|
|
Profit before income tax
|
|
58,874,548
|
|
30,681,458
|
|
|
Adjustments to reconcile profits to net cash provided by
operating activities
|
|
|
|
|
|
|
Fixed assets depreciation
|
17
|
763,079
|
|
636,285
|
|
|
Impairment Release/charge for credit
losses (Loans and advances to customers and banks)
|
4,226,051
|
|
1,088,174
|
|
|
Other provisions
Release/charge
|
22
|
429,182
|
|
2,350,347
|
|
|
Impairment Release/charge for credit
losses (due from banks)
|
|
(5)
|
|
(49,019)
|
|
|
Impairment Release/charge for
credit losses (financial investments)
|
|
(484,838)
|
|
209,742
|
|
|
Impairment Release/charge for other
assets
|
|
(11,956)
|
|
14,347
|
|
|
Exchange revaluation differences for
financial assets at fair value through OCI and AC
|
|
(18,536,183)
|
|
(5,409,592)
|
|
|
Revaluation differences Impairment
charge for Financial Assets at Fair value through OCI
|
1,199,896
|
|
-
|
|
|
Revaluation differences Impairment
charge for Financial Assets at Amortized cost
|
|
107,207
|
|
-
|
|
|
Revaluation differences Impairment
charge for due from banks
|
|
107
|
|
-
|
|
|
Utilization of other
provisions
|
22
|
(9,196)
|
|
(1,608)
|
|
|
Exchange revaluation differences of
other provisions
|
22
|
3,963,023
|
|
1,096,665
|
|
|
Profits/losses from selling property
and equipment
|
|
(2,254)
|
|
(194)
|
|
|
Profits/losses from selling
financial investments at fair value through OCI
|
14.1
|
(377,992)
|
|
(149,012)
|
|
|
Losses (Profits) from selling
investments in associates
|
14.1
|
-
|
|
(7,466)
|
|
|
Share based payments
|
|
804,345
|
|
608,250
|
|
|
Impairment Release/charges of
investments in associates and subsidiaries
|
14.1
|
-
|
|
1,412,711
|
|
|
Operating profits before changes in operating assets and
liabilities
|
|
50,945,014
|
|
32,481,088
|
|
|
|
|
|
|
|
|
|
Net
decrease / increase in assets and liabilities
|
|
|
|
|
|
|
Due from banks
|
|
(24,748,544)
|
|
5,142,259
|
|
|
Financial assets at fair value
through P&L
|
|
(2,066,889)
|
|
-
|
|
|
Derivative financial
instruments
|
|
(229,127)
|
|
172,635
|
|
|
Loans and advances to banks and
customers
|
12-13
|
(74,803,105)
|
|
(27,805,660)
|
|
|
Other assets
|
|
(14,036,648)
|
|
(2,507,984)
|
|
|
Due to banks
|
18
|
(8,606,431)
|
|
15,554,567
|
|
|
Due to customers
|
19
|
221,382,197
|
|
135,770,021
|
|
|
Current income tax obligations
paid
|
|
(2,694,657)
|
|
(2,547,087)
|
|
|
Other liabilities
|
|
(6,305,033)
|
|
874,366
|
|
|
Net
cash generated from (used in) operating
activities
|
|
138,836,777
|
|
157,134,205
|
|
|
|
|
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
|
|
|
Proceeds from sale of investments in
associates
|
|
11,956
|
|
2,119
|
|
|
Payments for investment in
subsidiaries
|
|
(200,000)
|
|
(1,216,022)
|
|
|
Payments for purchases of property,
equipment and branches construction
|
|
(2,284,236)
|
|
(1,162,819)
|
|
|
Proceeds from selling property and
equipment
|
|
2,254
|
|
194
|
|
|
Proceeds from redemption of
financial assets at amortized cost
|
|
1,093,724
|
|
5,278,030
|
|
|
Payments for purchases of financial
assets at amortized cost
|
|
(105,723,312)
|
|
(9,178,811)
|
|
|
Payments for purchases of financial
assets at fair value through OCI
|
|
(21,646,713)
|
|
(65,109,765)
|
|
|
Proceeds from selling financial
assets at fair value through OCI
|
|
67,015,091
|
|
76,347,190
|
|
|
Net
cash generated from (used in) investing
activities
|
|
(61,731,236)
|
|
4,960,116
|
|
|
|
Condensed Separate Interim Cash Flows for the period ended
September 30, 2024 (Cont.)
|
|
|
|
|
|
|
|
|
|
|
|
Sep. 30,
2024
|
|
Sep. 30,
2023
|
|
|
|
|
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
|
|
|
Other loans
|
|
7,840,786
|
|
2,408,739
|
|
|
Dividends paid
|
|
(5,078,792)
|
|
(3,738,888)
|
|
|
Issued debt instruments
|
|
1,738,393
|
|
615,227
|
|
|
Capital increase
|
|
236,570
|
|
369,876
|
|
|
Net
cash generated from (used in) financing
activities
|
|
4,736,957
|
|
(345,046)
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and
cash equivalent during the period
|
|
81,842,498
|
|
161,749,275
|
|
|
Beginning balance of cash and cash
equivalent
|
|
233,912,193
|
|
92,895,143
|
|
|
Cash and cash equivalent at the end of the
period
|
|
315,754,691
|
|
254,644,418
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalent comprise:
|
|
|
|
|
|
|
Cash and balances at the central
bank
|
9
|
94,285,689
|
|
59,818,535
|
|
|
Due from banks
|
|
304,041,410
|
|
276,244,266
|
|
|
Treasury bills and other
governmental notes
|
11
|
82,174,775
|
|
71,507,826
|
|
|
Obligatory reserve balance with
CBE
|
|
(76,128,521)
|
|
(52,853,882)
|
|
|
Due from banks with maturity more
than three months
|
|
(17,846,556)
|
|
(29,659,932)
|
|
|
Treasury bills and other
governmental notes with maturity more than three months
|
|
(70,772,106)
|
|
(70,412,395)
|
|
|
Total cash and cash equivalent
|
|
315,754,691
|
|
254,644,418
|
|
|
|
|
|
|
|
